following interferon therapy Philadelphia chromosome-positive chronic myelogenous leukemia Detection of minimal residual disease by polymerase chain reaction in
暂无分享,去创建一个
H. Kantarjian | A. Deisseroth | S. Stass | M. Talpaz | J. Trujillo | E. Freireich | Lee
[1] M. Slovak,et al. Persistence of bcr-able gene expression following bone marrow transplantation for chronic myelogenous leukemia in chronic phase. , 1991, Transplantation.
[2] G. Morgan,et al. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. , 1991, Blood.
[3] C. Sawyers,et al. Significance of residual leukaemia transcripts after bone marrow transplant for CML , 1990, The Lancet.
[4] J. Gabert,et al. DETECTION OF RESIDUAL bcr/abl TRANSLOCATION BY POLYMERASE CHAIN REACTION IN CHRONIC MYELOID LEUKAEMIA PATIENTS AFTER BONE-MARROW TRANSPLANTATION , 1989, The Lancet.
[5] D. Ginsburg,et al. Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia , 1989 .
[6] H. Kantarjian,et al. Clinical investigation of human alpha interferon in chronic myelogenous leukemia. , 1987, Blood.
[7] Kees Stam,et al. Structural organization of the bcr gene and its role in the Ph′ translocation , 1985, Nature.
[8] J. Stephenson,et al. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.
[9] G. Canellos,et al. Chronic granulocytic leukemia. , 1976, The Medical clinics of North America.
[10] J. Rowley. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.